More than 65 million Americans rely on the program for their health insurance, with a significant proportion of those being ...

The U.S. government said on Wednesday it will consider opportunities to "bring greater transparency" for the Medicare drug ...

The U.S. government said on Wednesday it will aim for "greater transparency" in Medicare drug price negotiations under ...

Trump stopped a program that had been in the works and was intended to give Medicare recipients access to more than 100 ...

President Donald Trump rescinded an executive order issued by former President Joe Biden aimed at finding new models for ...

The hugely popular medications Ozempic and Wegovy​, used for diabetes and weight loss, will be included in the next round of ...

The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by ...

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...

A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...

Trump has reversed some of President Biden’s initiatives, including $2 monthly out-of-pocket cap on some generics and ...

The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...